Red Herring, the venture capital magazine, has a piece on a company called Theranos, founded and being run by Elizabeth Holmes. The company has been developing a device which detects adverse drug reactions. It works by analyzing a tiny amount of blood from a person’s finger or arm, then transmitting the data to a Theranos server, which uses biostatistics algorithms to profile the information. In 2004, there were more than 400,000 adverse drug reactions reported to the FDA, and Ms Holmes wants this device to bring the numbers down. She also believes that the device could fundamentally change healthcare by determining of a particular drug is working on an individual basis.
She just turned 21 — and this is her second company. Theranos has funding from Draper Fisher Jurvetson, among others.